PortfoliosLab logo

Aptevo Therapeutics Inc. (APVO)

Equity · Currency in USD · Last updated Sep 23, 2022

Company Info

ISINUS03835L2079
CUSIP03835L207
SectorHealthcare
IndustryBiotechnology

Trading Data

Previous Close$3.40
Year Range$3.26 - $17.49
EMA (50)$3.86
EMA (200)$6.41
Average Volume$66.00K
Market Capitalization$18.36M

APVOShare Price Chart


Chart placeholderClick Calculate to get results

APVOPerformance

The chart shows the growth of $10,000 invested in Aptevo Therapeutics Inc. in Jul 2016 and compares it to the S&P 500 index or another benchmark. It would be worth nearly $294 for a total return of roughly -97.06%. All prices are adjusted for splits and dividends.


-50.00%-40.00%-30.00%-20.00%-10.00%0.00%AprilMayJuneJulyAugustSeptember
-45.76%
-17.86%
APVO (Aptevo Therapeutics Inc.)
Benchmark (^GSPC)

APVOReturns in periods

Returns over 1 year are annualized

PeriodReturnBenchmark
1M-7.32%-9.18%
6M-37.21%-15.67%
YTD-58.20%-21.15%
1Y-80.70%-13.69%
5Y-34.55%8.49%
10Y-43.56%9.35%

APVOMonthly Returns Heatmap


JanFebMarAprMayJunJulAugSepOctNovDec
2022-25.79%-1.37%1.91%-27.43%7.51%-21.83%10.06%-10.15%-7.06%
2021-8.59%-2.36%-6.70%-12.48%-2.21%-14.13%-16.32%-4.37%-13.98%-1.30%-34.65%-20.98%
2020-9.85%-27.12%-38.54%35.14%14.00%46.49%0.60%-6.67%-3.06%-15.00%576.93%-16.19%
201925.98%-5.00%-40.79%-19.11%-0.41%22.28%0.39%-22.09%-15.14%-5.27%16.61%0.69%
2018-20.05%-6.49%3.15%35.47%25.51%-10.25%-15.43%30.81%-7.97%-33.66%-31.75%-44.78%
2017-18.44%0.50%3.00%-2.91%5.50%-1.90%-11.11%-27.72%72.18%24.67%5.43%40.86%
2016-53.62%-26.68%-5.88%-13.67%-14.03%28.42%

APVOSharpe Ratio Chart

The Sharpe ratio shows whether the portfolio's excess returns are due to smart investment decisions or a result of taking a higher risk. The higher a portfolio's Sharpe ratio, the better its risk-adjusted performance.

The current Aptevo Therapeutics Inc. Sharpe ratio is -0.42. A negative Sharpe ratio means that the risk-free rate is higher than the portfolio's return. This value does not convey any meaningful information.

The chart below displays rolling 12-month Sharpe Ratio.


-0.500.000.501.00AprilMayJuneJulyAugustSeptember
-0.42
-0.67
APVO (Aptevo Therapeutics Inc.)
Benchmark (^GSPC)

APVODividend History


Aptevo Therapeutics Inc. doesn't pay dividends

APVODrawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way.


-100.00%-80.00%-60.00%-40.00%-20.00%0.00%OctoberNovemberDecember2022FebruaryMarchAprilMayJuneJulyAugustSeptember
-97.06%
-21.65%
APVO (Aptevo Therapeutics Inc.)
Benchmark (^GSPC)

APVOWorst Drawdowns

The table below shows the maximum drawdowns of the Aptevo Therapeutics Inc.. A maximum drawdown is an indicator of risk. It shows a reduction in portfolio value from its maximum due to a series of losing trades.

The maximum drawdown since January 2010 for the Aptevo Therapeutics Inc. is 97.22%, recorded on Apr 3, 2020. The portfolio has not recovered from it yet.


Depth

Start

To Bottom

Bottom

To Recover

End

Total

-97.22%Jul 22, 2016932Apr 3, 2020

APVOVolatility Chart

Current Aptevo Therapeutics Inc. volatility is 64.16%. The chart below shows the rolling 10-day volatility. Volatility is a statistical measure showing how big price swings are in either direction. The higher asset volatility, the riskier it is, because the price movements are less predictable.


0.00%50.00%100.00%150.00%200.00%AprilMayJuneJulyAugustSeptember
64.16%
25.76%
APVO (Aptevo Therapeutics Inc.)
Benchmark (^GSPC)